Scientific Opinion on the substantiation of health claims related to various food(s)/food constituent(s) claiming maintenance of normal blood glucose concentrations (ID 1987, 2091, 2135, 2179, 2335, 2461, 2642, 3145, 3230, 3244, 3258, 3291, 3345, 3375, 3408, 3438, 3457, 3471, 3528, 3534, 3540, 3554, 3557, 3583, 3625, 3628, 3730, 3782, 3851, 3971, 4034, 4043) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen.
Acknowledgment
The Panel wishes to thank for the preparation of this opinion: The members of the Working Group on Claims : Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Marina Heinonen, Hannu Korhonen, Martinus Løvik, Ambroise Martin, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Inge Tetens, Hendrik van Loveren and Hans Verhagen. The members of the Claims Sub-Working Group on Weight Management/Satiety/Glucose and Insulin Control/Physical Performance: Kees de Graaf, Joanne Harrold, Mette Hansen, Mette Kristensen, Anders Sjödin and Inge Tetens.
Contact
nda@efsa.europa.eu
No abstract available
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to food(s)/food constituent(s) and maintenance of normal blood glucose concentrations. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders.
The claimed effects are “contributes/help maintain a healthy blood sugar level”, “glucose metabolism”, “glycaemic health”, “sugar metabolism”, and “digestion and metabolism of carbohydrates”. The target population is assumed to be the general population. The Panel considers that long-term maintenance of normal blood glucose concentrations is a beneficial physiological effect.
No studies in humans investigating the effects of the food(s)/food constituent(s) on blood glucose concentrations in healthy subjects, in subjects with impaired glucose tolerance or in diabetic subjects not on anti-diabetic medications have been provided in relation to any of the health claims evaluated in this opinion. The evidence provided by studies conducted in subjects with diagnosis of type 2 diabetes under conventional oral anti-diabetic medications and/or insulin therapy does not predict the occurrence of an effect of the food(s)/food constituent(s) on maintenance or achievement of normal blood glucose concentrations in the general population. The evidence provided in the animal and in vitro studies submitted is not sufficient to predict the occurrence of an effect of the food(s)/food constituent(s) on maintenance or achievement of normal blood glucose concentrations in vivo in humans.
On the bases of the data presented, the Panel concludes that a cause and effect relationship has not been established between the consumption of the food(s)/food constituent(s) evaluated in this opinion and long-term maintenance of normal blood glucose concentrations.
Blood sugar, glucose metabolism, carbohydrates, health claims.
